Cencora Inc (NYSE: COR) open the trading on Wednesday, with a bit cautious approach as it glided -2.93% to $283.78, before settling in for the price of $292.35 at the close. Taking a more long-term approach, COR posted a 52-week range of $218.65-$309.35.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 13.29%. Meanwhile, its Annual Earning per share during the time was 13.29%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 15.53%. This publicly-traded company’s shares outstanding now amounts to $193.86 million, simultaneously with a float of $183.50 million. The organization now has a market capitalization sitting at $55.00 billion. At the time of writing, stock’s 50-day Moving Average stood at $292.72, while the 200-day Moving Average is $264.61.
Cencora Inc (COR) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Distribution industry. Cencora Inc’s current insider ownership accounts for 5.33%, in contrast to 94.50% institutional ownership. According to the most recent insider trade that took place on Jul 22 ’25, this organization’s Executive Chairman sold 14,578 shares at the rate of 292.67, making the entire transaction reach 4,266,543 in total value, affecting insider ownership by 309,913. Preceding that transaction, on Jul 18 ’25, Company’s President & CEO sold 4,968 for 294.11, making the whole transaction’s value amount to 1,461,138. This particular insider is now the holder of 42,351 in total.
Cencora Inc (COR) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 4.08 per share during the current fiscal year.
Cencora Inc’s EPS increase for this current 12-month fiscal period is 15.53% and is forecasted to reach 17.45 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 11.81% through the next 5 years, which can be compared against the 13.29% growth it accomplished over the previous five years trading on the market.
Cencora Inc (NYSE: COR) Trading Performance Indicators
Let’s observe the current performance indicators for Cencora Inc (COR). It’s Quick Ratio in the last reported quarter now stands at 0.50. Alongside those numbers, its PE Ratio stands at $29.20, and its Beta score is 0.62. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.17. Similarly, its price to free cash flow for trailing twelve months is now 48.18.
In the same vein, COR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 9.72, a figure that is expected to reach 3.82 in the next quarter, and analysts are predicting that it will be 17.45 at the market close of one year from today.
Technical Analysis of Cencora Inc (COR)
[Cencora Inc, COR] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 74.14% While, its Average True Range was 36.93%.
Raw Stochastic average of Cencora Inc (COR) in the period of the previous 100 days is set at 55.03%, which indicates a major rise in contrast to 44.88% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 5.81 that was lower than 5.93 volatility it exhibited in the past 100-days period.